Literature DB >> 2029077

Ifosfamide-induced Fanconi's syndrome with growth failure in a 2-year-old child.

J De Schepper1, G Stevens, M Verboven, C Baeta, J Otten.   

Abstract

Fanconi's syndrome with phosphopenic rickets is described in a 2-year-old girl who had been treated for an embryonal sarcoma with multiagent chemotherapy including high-dose ifosfamide. The radiological and biochemical signs of rickets disappeared after treatment with 25-OH vitamin D3 and phosphorus supplements. Monitoring of tubular function in children during and after treatment with ifosfamide is mandatory.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2029077     DOI： 10.1097/00043426-199121000-00009

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN： 0192-8562


  6 in total

Review 1.  Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors:  K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide.

Authors:  J de Schepper; S Hachimi-Idrissi; O Louis; R Maurus; J Otten
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

Review 3.  Anticancer drug-induced kidney disorders.

Authors:  P E Kintzel
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.228

4.  The influence of ifosfamide scheduling on acute nephrotoxicity in children.

Authors:  M W English; R Skinner; A D Pearson; L Price; R Wyllie; A W Craft
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group.

Authors:  R Skinner; S J Cotterill; M C Stevens
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

6.  Downregulation of oxidative and nitrosative apoptotic signaling by L-carnitine in Ifosfamide-induced Fanconi syndrome rat model.

Authors:  Mohamed M Sayed-Ahmed; Mohamed M Hafez; Meshan Lafi Aldelemy; Abdulaziz M Aleisa; Salem S Al-Rejaie; Khaled A Al-Hosaini; Naif O Al-Harbi; Mohamed M Al-Harbi; Othman A Al-Shabanah
Journal:  Oxid Med Cell Longev       Date:  2012-11-13       Impact factor: 6.543
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.